Pricing Log in Create free account
Saturday 17 October 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%
Market cap
$34.8B
P/E
41.0×
Fwd P/E
31.5×
Dividend yield
—
F-score
4/9
Altman Z
3.13
Beneish M
−2.67
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Biogen Inc. (BIIB) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Biogen Inc. (BIIB) trades at a EV/EBITDA of 15.7×. Over the past ten years it has ranged from 5.6× (October 2019) to 23.9× (March 2015); the current reading is higher than 90% of that period. That is above the Drug Manufacturers General industry median of 13.8× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 9.6× 24.17%
FY2024 7.8× (62.73%)
FY2023 20.8× 109.06%
FY2022 9.9× 2.95%
FY2021 9.7× 20.31%
FY2020 8.0× 11.77%
FY2019 7.2× (26.64%)
FY2018 9.8× (14.10%)
FY2017 11.4× 1.85%
FY2016 11.2× (16.65%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 14.7× 53.78%
Mar 2026 9.6× (0.61%)
Dec 2025 9.6× 33.14%
Sep 2025 7.2× (0.19%)
42 more quarters

Against its own ten years

Low 5.6× High 23.9×
Ten-year median 10.4×
Current reading's percentile 90

EV/EBITDA against peers

Company EV/EBITDA
NVO Novo Nordisk A/S compare 7.0×
GSK GSK PLC Sponsored ADR compare 9.3×
BMY Bristol Myers Squibb Company compare 10.2×
PFE Pfizer Inc. compare 10.8×
SNY Sanofi compare 11.1×
AZN AstraZeneca PLC compare 13.8×
BIIB Biogen Inc. 15.7×
AMGN Amgen Inc. compare 16.8×
GILD Gilead Sciences, Inc. compare 829×
Drug Manufacturers General industry median 13.8×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BIIB